It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CGON’s FA Score shows that 0 FA rating(s) are green while.
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CGON’s TA Score shows that 4 TA indicator(s) are bullish.
CGON (@Biotechnology) experienced а +3.86% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +6.06%. For the same industry, the average monthly price growth was +18.18%, and the average quarterly price growth was +35.10%.
CGON is expected to report earnings on Aug 07, 2025.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
CGON | GDOC | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 2 days ago82% | 2 days ago80% |
Momentum ODDS (%) | 2 days ago71% | 2 days ago73% |
MACD ODDS (%) | 2 days ago75% | 2 days ago77% |
TrendWeek ODDS (%) | 2 days ago75% | 2 days ago81% |
TrendMonth ODDS (%) | 2 days ago73% | 2 days ago82% |
Advances ODDS (%) | 6 days ago73% | N/A |
Declines ODDS (%) | 8 days ago83% | 15 days ago83% |
BollingerBands ODDS (%) | 2 days ago90% | 2 days ago74% |
Aroon ODDS (%) | N/A | 2 days ago81% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TRTIX | 21.23 | 0.13 | +0.62% |
T. Rowe Price International Value Eq I | |||
EDIRX | 11.24 | 0.01 | +0.06% |
Eaton Vance Global Income Builder R | |||
JRGRX | 29.72 | -0.03 | -0.10% |
JHancock Regional Bank R6 | |||
OGIIX | 51.92 | -0.15 | -0.29% |
Invesco Global Opportunities R6 | |||
AGIRX | 19.99 | -0.13 | -0.65% |
Alger Mid Cap Growth Institutional R |
A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.
Ticker / NAME | Correlation To CGON | 1D Price Change % | ||
---|---|---|---|---|
CGON | 100% | -5.48% | ||
IDYA - CGON | 61% Loosely correlated | +1.02% | ||
SYRE - CGON | 58% Loosely correlated | +0.37% | ||
KYMR - CGON | 57% Loosely correlated | -2.25% | ||
ACLX - CGON | 56% Loosely correlated | +2.67% | ||
NUVL - CGON | 55% Loosely correlated | -1.13% | ||
More |
A.I.dvisor indicates that over the last year, GDOC has been loosely correlated with CGON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GDOC jumps, then CGON could also see price increases.
Ticker / NAME | Correlation To GDOC | 1D Price Change % | ||
---|---|---|---|---|
GDOC | 100% | -1.79% | ||
CGON - GDOC | 49% Loosely correlated | -5.48% | ||
NTRA - GDOC | 44% Loosely correlated | +1.25% | ||
ABBV - GDOC | 43% Loosely correlated | -2.33% | ||
MRK - GDOC | 42% Loosely correlated | -0.81% | ||
MLTX - GDOC | 36% Loosely correlated | -1.13% | ||
More |